The UK ALLR3 Chemotherapy Regimen for Relapsed/Refractory Acute Lymphoblastic Leukemia of Childhood: A Multi-Institutional Retrospective Study of Treatment Related Adverse Events
Weili Sun(City Of Hope National Medical Center), Alan S. Wayne(University of Southern California), Susan R. Rheingold(Children's Hospital of Philadelphia), Jennifer J. Wilkes(University of Washington), Richard Sposto(Children's Hospital of Los Angeles), Orgal Etan(University of Southern California), Michael J. Burke(Children's Hospital of Wisconsin), Rebecca Gardner(Seattle Children's Hospital), Vanessa Pineros(Seattle Children's Hospital), Alison Smith(University of Southern California), Yijuin Tan(Children's Hospital of Los Angeles), Minjun Hur, Emily M. Olson
Cited by 4
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
The treatment of medulloblastoma
|Journal of neurosurgery|1990|583
Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2012|433